Selections from current literature: pharmacological treatment of obesity

被引：1

作者：

Connolly, J ^{[1
]}

Verni, C ^{[1
]}

Trilling, J ^{[1
]}

Kelso, E ^{[1
]}

Shiesha, S ^{[1
]}

机构：

[1] SUNY Stony Brook, Dept Family Med, Stony Brook, NY 11794 USA

来源：

FAMILY PRACTICE | 1998年 / 15卷 / 01期

关键词：

D O I：

10.1093/fampra/15.1.88

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页码：88 / 93

页数：6

共 22 条

[1]

*AM DIET ASS, 1997, J AM DIET ASSOC, V1, P71

[2] NEUROENDOCRINE ABNORMALITIES IN HUMAN OBESITY [J].

BJORNTORP, P .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (02) :38-41

[3]

BREMER JM, 1994, INT J OBESITY, V18, P199

[4] THE HETEROGENEITY OF OBESITY - FITTING TREATMENTS TO INDIVIDUALS [J].

BROWNELL, KD ;

WADDEN, TA .

BEHAVIOR THERAPY, 1991, 22 (02) :153-177

[5] GENETIC-VARIATION IN THE BETA(3)-ADRENERGIC RECEPTOR AND AN INCREASED CAPACITY TO GAIN WEIGHT IN PATIENTS WITH MORBID-OBESITY [J].

CLEMENT, K ;

VAISSE, C ;

MANNING, BS ;

BASDEVANT, A ;

GUYGRAND, B ;

RUIZ, J ;

SILVER, KD ;

SHULDINER, AR ;

FROGUEL, P ;

STROSBERG, AD .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (06) :352-354

[6]

*COMM DEV CRIT EV, 1995, WEIGH OPT CRIT EV WE, P5

[7] Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].

Considine, RV ;

Sinha, MK ;

Heiman, ML ;

Kriauciunas, A ;

Stephens, TW ;

Nyce, MR ;

Ohannesian, JP ;

Marco, CC ;

McKee, LJ ;

Bauer, TL ;

Caro, JF .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295

[8]

GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397

[9]

GUYGRAND B, 1989, LANCET, V2, P1142

[10]

LEVITSKY DA, 1992, AM J CLIN NUTR, V55, P167

← 1 2 3 →